Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
Multiple Institutes
Application Receipt Date(s): November 27, 2018; February 11, 2019; July 11, 2019; November 12, 2019.
• Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
Multiple Institutes
Application Receipt Date(s): November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020.
• Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center: Synergizing Career Development toward Improved Care of Older Adults across Specialties and Disciplines (U24 - Clinical Trial Optional)
National Institute on Aging
Application Receipt Date(s): February 4, 2019.
• NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 Non-Construction (Admin Supp Clinical Trial Optional)
Multiple Institutes
Application Receipt/Submission Date(s): December 14, 2018.
• Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)
Multiple Institutes
Application Receipt/Submission Date(s): Standard dates.
• Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)
Multiple Institutes
Application Receipt/Submission Date(s): Standard dates apply.
• Clinical and Translational Science Award (U54 Clinical Trial Optional)
National Center for Advancing Translational Sciences
Application Receipt/Submission Date(s): January 25, 2019, April 15, 2019, August 15, 2019, December 16, 2019, April 15, 2020, August 17, 2020, December 15, 2020, April 15, 2021, August 15, 2021.
• Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)
National Institute of Mental Health
Application Receipt/Submission Date(s): November 26, 2018.
• Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)
National Institute of Mental Health
Application Receipt/Submission Date(s): November 26, 2018.
• Development Innovation Ventures (DIV) is Accepting New Applications! Do you have a breakthrough idea to solve a global development problem? USAID wants to hear from you! USAID's open innovation program - Development Innovation Ventures (DIV) - is accepting new applications to test and scale creative solutions to any global development challenge. Anyone, anywhere can apply at any time. DIV provides tiered grant funding (from $50,000 to $5,000,000) to test new ideas and scale the best solutions that demonstrate rigorous evidence of impact, cost-effectiveness, and a viable pathway to scale. For more information and how to apply, please visit:
https://www.usaid.gov/div
• MR3 Network Opportunities
o TREAT has a two-phase application procedure for pilot grants. Abstracts are reviewed on a revolving basis to determine if the product falls within TREAT‘s expertise and mission. If accepted, applicants are then asked to complete a more comprehensive proposal that will be assessed by a multidisciplinary panel of technical, business, and clinical experts during one of our triannual review sessions.
Abstract: January 8, 2019
Proposal: January 22, 2019